1. Dose‐dependent efficacy of the glucose‐dependent insulinotropic polypeptide (GIP) receptor antagonist GIP(3‐30)NH2 on GIP actions in humans. Issue 1 (1st October 2020) Authors: Gasbjerg, Lærke Smidt; Bari, Emilie J.; Stensen, Signe; Hoe, Bjørn; Lanng, Amalie R.; Mathiesen, David S.; Christensen, Mikkel B.; Hartmann, Bolette; Holst, Jens J.; Rosenkilde, Mette M.; Knop, Filip Krag Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 1(2021) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-acting amylin analogues for the management of obesity. Issue 2 (21st April 2022) Authors: Mathiesen, David S.; Bagger, Jonatan I.; Knop, Filip K. Journal: Current opinion in endocrinology, diabetes and obesity Issue: Volume 29:Issue 2(2022) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗